North American Scientific (NASM) Reports Q2 Loss of $0.05
North American Scientific, Inc. (Nasdaq: NASM) reports a Q2 loss of $0.05, versus an $0.11 loss in Q207. Revenues for the quarter were $4.64 million, compared to $3.79 million in the same period last year.
North American Scientific, Inc. designs, develops, manufactures, and sells radioisotopic products for the treatment of cancer.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
